Market Closed -
Nasdaq
04:00:00 2024-05-08 pm EDT
|
5-day change
|
1st Jan Change
|
22.14
USD
|
+5.88%
|
|
+4.14%
|
+59.05%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
920.9
|
1,637
|
657.3
|
325.8
|
416.6
|
665.2
|
-
|
-
|
Enterprise Value (EV)
1 |
920.9
|
1,637
|
657.3
|
325.8
|
416.6
|
665.2
|
665.2
|
665.2
|
P/E ratio
|
-
|
112
x
|
256
x
|
49.9
x
|
31.6
x
|
27.7
x
|
23.4
x
|
20.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.72
x
|
4.19
x
|
1.49
x
|
0.69
x
|
0.76
x
|
1.06
x
|
0.98
x
|
0.9
x
|
EV / Revenue
|
2.72
x
|
4.19
x
|
1.49
x
|
0.69
x
|
0.76
x
|
1.06
x
|
0.98
x
|
0.9
x
|
EV / EBITDA
|
14.8
x
|
21.8
x
|
9.83
x
|
4.8
x
|
5.26
x
|
7.32
x
|
6.53
x
|
5.81
x
|
EV / FCF
|
327
x
|
-
|
-26.8
x
|
-63.6
x
|
-
|
35
x
|
34.6
x
|
26.4
x
|
FCF Yield
|
0.31%
|
-
|
-3.73%
|
-1.57%
|
-
|
2.86%
|
2.89%
|
3.79%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
27,847
|
28,190
|
28,477
|
29,677
|
29,927
|
30,046
|
-
|
-
|
Reference price
2 |
33.07
|
58.06
|
23.08
|
10.98
|
13.92
|
22.14
|
22.14
|
22.14
|
Announcement Date
|
3/4/20
|
2/24/21
|
2/28/22
|
2/23/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
338.5
|
391
|
439.7
|
473.2
|
544.9
|
626.8
|
675.8
|
739.1
|
EBITDA
1 |
62.11
|
75.05
|
66.87
|
67.96
|
79.2
|
90.85
|
101.9
|
114.5
|
EBIT
1 |
23.35
|
31.4
|
62.09
|
63.06
|
35.59
|
43.76
|
50.69
|
53.72
|
Operating Margin
|
6.9%
|
8.03%
|
14.12%
|
13.32%
|
6.53%
|
6.98%
|
7.5%
|
7.27%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
19.58
|
-
|
49.58
|
53.72
|
Net income
1 |
-
|
15.74
|
2.696
|
6.643
|
13.38
|
24.36
|
29.23
|
33.7
|
Net margin
|
-
|
4.03%
|
0.61%
|
1.4%
|
2.46%
|
3.89%
|
4.32%
|
4.56%
|
EPS
2 |
-
|
0.5200
|
0.0900
|
0.2200
|
0.4400
|
0.8000
|
0.9450
|
1.075
|
Free Cash Flow
1 |
2.82
|
-
|
-24.53
|
-5.126
|
-
|
19
|
19.2
|
25.2
|
FCF margin
|
0.83%
|
-
|
-5.58%
|
-1.08%
|
-
|
3.03%
|
2.84%
|
3.41%
|
FCF Conversion (EBITDA)
|
4.54%
|
-
|
-
|
-
|
-
|
20.91%
|
18.84%
|
22.01%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
78.01%
|
65.69%
|
74.77%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
2/24/21
|
2/28/22
|
2/23/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
111.8
|
223.7
|
113.9
|
116.3
|
118.4
|
124.7
|
126.5
|
132.3
|
140.2
|
146
|
156.9
|
156.6
|
158.9
|
162.4
|
167.2
|
169.7
|
EBITDA
1 |
15.3
|
32.03
|
15.23
|
16.63
|
16.97
|
19.12
|
17.14
|
19.48
|
20.65
|
21.93
|
21.4
|
22.33
|
23.22
|
24.45
|
24.03
|
25.1
|
EBIT
1 |
14.06
|
-
|
4.998
|
6.329
|
6.644
|
17.9
|
6.51
|
8.854
|
9.557
|
10.54
|
9.893
|
10.59
|
11.53
|
12.64
|
10.45
|
12.14
|
Operating Margin
|
12.58%
|
-
|
4.39%
|
5.44%
|
5.61%
|
14.36%
|
5.15%
|
6.69%
|
6.82%
|
7.22%
|
6.3%
|
6.76%
|
7.25%
|
7.78%
|
6.25%
|
7.15%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
6.068
|
5.095
|
2.904
|
4.843
|
5.528
|
6.309
|
6.817
|
8.64
|
9.66
|
10.86
|
8.721
|
10.46
|
Net income
1 |
-2.149
|
-
|
1.014
|
-2.676
|
4.831
|
3.474
|
1.85
|
2.797
|
4.383
|
4.349
|
4.906
|
5.776
|
6.451
|
7.222
|
6.092
|
6.966
|
Net margin
|
-1.92%
|
-
|
0.89%
|
-2.3%
|
4.08%
|
2.79%
|
1.46%
|
2.11%
|
3.13%
|
2.98%
|
3.13%
|
3.69%
|
4.06%
|
4.45%
|
3.64%
|
4.1%
|
EPS
2 |
-0.0800
|
-
|
0.0300
|
-0.0900
|
0.1600
|
0.1200
|
0.0600
|
0.0900
|
0.1500
|
0.1400
|
0.1600
|
0.1900
|
0.2100
|
0.2350
|
0.2000
|
0.2250
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/28/22
|
2/28/22
|
5/9/22
|
8/8/22
|
11/7/22
|
2/23/23
|
5/4/23
|
8/8/23
|
11/7/23
|
2/28/24
|
5/6/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2.82
|
-
|
-24.5
|
-5.13
|
-
|
19
|
19.2
|
25.2
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
16.5%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-0.5900
|
0.3000
|
-
|
-
|
-
|
-
|
Capex
|
6.73
|
-
|
6.3
|
14.2
|
-
|
-
|
-
|
-
|
Capex / Sales
|
1.99%
|
-
|
1.43%
|
2.99%
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
2/24/21
|
2/28/22
|
2/23/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
22.14
USD Average target price
23.5
USD Spread / Average Target +6.14% Consensus |
1st Jan change
|
Capi.
|
---|
| +59.05% | 628M | | -1.03% | 3.02B | | 0.00% | 1.97B | | +15.34% | 1.69B | | -6.28% | 497M | | -37.39% | 363M | | -25.75% | 158M | | -12.24% | 141M | | +3.85% | 67.76M |
Home Healthcare Services
|